Global mRNA CDMO Service Market Growth (Status and Outlook) 2024-2030

Global mRNA CDMO Service Market Growth (Status and Outlook) 2024-2030

mRNA CDMO Service is a professional service provided by a contract development and manufacturing organization (CDMO), covering the entire process from the research and development of mRNA drugs to large-scale production. mRNA technology is widely used in the fields of vaccines and gene therapy. mRNA CDMO service providers provide pharmaceutical companies and biotechnology companies with full support from process development, raw material preparation, purification, formulation optimization to GMP-level production, helping to quickly advance mRNA drugs from research and development to the market.

The global mRNA CDMO Service market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “mRNA CDMO Service Industry Forecast” looks at past sales and reviews total world mRNA CDMO Service sales in 2022, providing a comprehensive analysis by region and market sector of projected mRNA CDMO Service sales for 2023 through 2029. With mRNA CDMO Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA CDMO Service industry.

This Insight Report provides a comprehensive analysis of the global mRNA CDMO Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on mRNA CDMO Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global mRNA CDMO Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA CDMO Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA CDMO Service.

United States market for mRNA CDMO Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for mRNA CDMO Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for mRNA CDMO Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key mRNA CDMO Service players cover Hongene Biotech, Sigma-Aldrich, TriLink BioTechnologies, AGC Biologics, Aldevron, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of mRNA CDMO Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
Process Development
Raw Material Preparation
Others

Segmentation by Application:
Personalized Cancer Treatment
Vaccine Development
Gene Therapy
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Process Development
Raw Material Preparation
Others

Segmentation by Application:
Personalized Cancer Treatment
Vaccine Development
Gene Therapy
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Hongene Biotech
Sigma-Aldrich
TriLink BioTechnologies
AGC Biologics
Aldevron
Samsung Biologics
GenScript ProBio
Patheon
Catalent
BioCina
Ricoh

Please note: The report will take approximately 2 business days to prepare and deliver.